D-128-2013 Class III Terminated
FDA drug recall D-128-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Apr 24, 2012 and is designated Class III. Reason for recall: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life The recall status is terminated (terminated Dec 18, 2013). Affected quantity: 13,232 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jan 23, 2013
- Initiation Date
- Apr 24, 2012
- Termination Date
- Dec 18, 2013
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 13,232 bottles
Product description
CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88
Reason for recall
Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life
Distribution pattern
Nationwide
Code information
Lot number 6A007046V, exp 07/12
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-128-2013
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026